Key Laboratory for Experimental Teratology of the Ministry of Education, Department of Medical Genetics, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China.
Key Laboratory for Experimental Teratology of the Ministry of Education, Department of Medical Genetics, School of Basic Medical Sciences, Shandong University, School of Health and Life Sciences University of Health and Rehabilitation Sciences, Qingdao, People's Republic of China.
Am J Physiol Endocrinol Metab. 2024 Jun 1;326(6):E776-E790. doi: 10.1152/ajpendo.00387.2023. Epub 2024 Apr 3.
Obesity has become a major risk of global public health. SMEK1 is also known as a regulatory subunit of protein phosphatase 4 (PP4). Both PP4 and SMEK1 have been clarified in many metabolic functions, including the regulation of hepatic gluconeogenesis and glucose transporter gene expression in yeast. Whether SMEK1 participates in obesity and the broader metabolic role in mammals is unknown. Thus, we investigated the function of SMEK1 in white adipose tissue and glucose uptake. GWAS/GEPIA/GEO database was used to analyze the correlation between SMEK1 and metabolic phenotypes/lipid metabolism-related genes/obesity. KO mice were generated to identify the role of SMEK1 in obesity and glucose homeostasis. Cell culture and differentiation of stromal-vascular fractions (SVFs) and 3T3-L1 were used to determine the mechanism. 2-NBDG was used to measure the glucose uptake. Compound C was used to confirm the role of AMPK. We elucidated that SMEK1 was correlated with obesity and adipogenesis. deletion enhanced adipogenesis in both SVFs and 3T3-L1. KO protected mice from obesity and had protective effects on metabolic disorders, including insulin resistance and inflammation. KO mice had lower levels of fasting serum glucose. We found that SMEK1 ablation promoted glucose uptake by increasing p-AMPKα(T172) and the transcription of when the effect on AMPK-regulated glucose uptake was due to the PP4 catalytic subunits (PPP4C). Our findings reveal a novel role of SMEK1 in obesity and glucose homeostasis, providing a potential new therapeutic target for obesity and metabolic dysfunction. Our study clarified the relationship between SMEK1 and obesity for the first time and validated the conclusion in multiple ways by combining available data from public databases, human samples, and animal models. In addition, we clarified the role of SMEK1 in glucose uptake, providing an in-depth interpretation for the study of its function in glucose metabolism.
肥胖已成为全球公共卫生的主要风险之一。SMEK1 也被称为蛋白磷酸酶 4(PP4)的调节亚基。PP4 和 SMEK1 都在许多代谢功能中得到了阐明,包括酵母中肝糖异生和葡萄糖转运基因表达的调节。SMEK1 是否参与肥胖和哺乳动物更广泛的代谢作用尚不清楚。因此,我们研究了 SMEK1 在白色脂肪组织和葡萄糖摄取中的功能。GWAS/GEPIA/GEO 数据库用于分析 SMEK1 与代谢表型/脂质代谢相关基因/肥胖之间的相关性。生成 KO 小鼠以确定 SMEK1 在肥胖和葡萄糖稳态中的作用。细胞培养和基质血管部分(SVF)和 3T3-L1 的分化用于确定机制。使用 2-NBDG 测量葡萄糖摄取。使用 Compound C 确认 AMPK 的作用。我们阐明了 SMEK1 与肥胖和脂肪生成有关。缺失增强了 SVF 和 3T3-L1 中的脂肪生成。KO 保护小鼠免受肥胖,并对代谢紊乱具有保护作用,包括胰岛素抵抗和炎症。KO 小鼠的空腹血清葡萄糖水平较低。我们发现 SMEK1 缺失通过增加 p-AMPKα(T172)和促进葡萄糖摄取来增加,当 AMPK 调节的葡萄糖摄取的作用归因于 PP4 催化亚基(PPP4C)时。我们的研究结果揭示了 SMEK1 在肥胖和葡萄糖稳态中的新作用,为肥胖和代谢功能障碍提供了一个新的潜在治疗靶点。我们的研究首次阐明了 SMEK1 与肥胖之间的关系,并通过结合来自公共数据库、人类样本和动物模型的现有数据,以多种方式验证了这一结论。此外,我们阐明了 SMEK1 在葡萄糖摄取中的作用,为研究其在葡萄糖代谢中的功能提供了深入的解释。